Glibenclamide Induces Apoptosis through Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl− Channels and Intracellular Ca2+ Release in HepG2 Human Hepatoblastoma Cells
Authors:
- Jung-Ae KimJKJung-Ae Kim
- Young Shin KangYKYoung Shin Kang
- Sun Hee LeeSLSun Hee Lee
- Eun-Hee LeeELEun-Hee Lee
- Byong Hoon YooBYByong Hoon Yoo
- Yong Soo LeeYLYong Soo Lee
- 1 August 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 261 (3) , 682-688
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Programmed Cellular Response in Radiation Oncology: Basic and Translational StudiesActa Oncologica, 1998
- Glibenclamide: an old drug with a novel mechanism of action?Acta Diabetologica, 1997
- cAMP- and Ca2+-independent Activation of Cystic Fibrosis Transmembrane Conductance Regulator Channels by Phenylimidazothiazole DrugsJournal of Biological Chemistry, 1996
- An Evaluation of the Role of Calcium in Cell InjuryAnnual Review of Pharmacology and Toxicology, 1995
- Inhibition of ATP‐sensitive potassium channels causes reversible cell‐cycle arrest of human breast cancer cells in tissue cultureJournal of Cellular Physiology, 1995
- Membrane potential regulates Ca2+ uptake and inositol phosphate generation in rat sublingual mucous aciniCell Calcium, 1993
- Expression and chromosome localization of the murine cystic fibrosis transmembrane conductance regulatorGenomics, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Long-term adjuvant tamoxifen therapy for breast cancerBreast Cancer Research and Treatment, 1990
- The role of surface charge and hydrophobic interaction in the activation of rat liver adenylate cyclaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1983